Hermann Druckrey, Eva Müller, Margarete Stuhlmann: Die Beeinflussung der sedativen Wirkung durch Antipyretika und Coffein. In: Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie. 185, 1937, S. 221, doi:10.1007/BF01925281.
espacenet.com
worldwide.espacenet.com
DE 22571, "Verfahren dur Darstellung von Bromodiäthylacetylharnstoff [Method for the preparation of bromodiethylacetylurea]", published 1910-09-17, assigned to Friedrich Bayer & Co.
Bioassay of carbromal for possible carcinogenicity. In: National Cancer Institute carcinogenesis technical report series. Band 173, 1979, S. 1–135, PMID 12799690.
P. Borrie: A purpuric drug eruption caused by carbromal. In: British medical journal. Bd. 1, Nr. 4914, März 1955, S. 645–646, PMID 13230580, PMC2061381.
H. W. Buck, J. C. Mitchell: Dermatitis Medicamentosa Caused by Diethyl Bromacetyl Carbamide (Carbromal). In: Canadian Medical Association journal. Bd. 89, Nr. 9, August 1963, S. 419, PMID 20327677, PMC1921693.
M. Steel, J. M. Johnstone: Addiction to carbromal. In: British medical journal. Band 2, Nummer 5143, August 1959, S. 118, PMID 13671224, PMC1989911.
D. Lugassy, L. Nelson: Case files of the medical toxicology fellowship at the New York City poison control: bromism: forgotten, but not gone. In: Journal of medical toxicology : official journal of the American College of Medical Toxicology. Band 5, Nummer 3, September 2009, S. 151–157, PMID 19655290, PMC3550397.
